Figure 2
From: Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion

OES of free NTAPPJ in air (a) and 2 mm above the NTAPPJ–liquid interface (b).
From: Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion

OES of free NTAPPJ in air (a) and 2 mm above the NTAPPJ–liquid interface (b).